Stocks in the Indian Pharmaceutical Industry have been a hit and miss in recent times. Prices have been soaring and sliding with no real patterns emerging from the industry as a whole. In May 2017 the Pharma Index (NIFTY) was at its lowest point in the last three years while in Sep 2017 the prices were on a sharp rise and had gained an incredible 11% even though the whole market was on a low. Continue reading